在一个孤立的希腊人口中,急性冠状动脉综合征在COVID-19大流行期间并没有减少
Matthaios Didagelos1, Dimitrios Afendoulis2, Eleni Karlafti3
11st Cardiology Department, AHEPA University General Hospital, Thessaloniki, Greece.
Global cardiology science & practice
|October 1, 2024
概括
由于急性冠状动脉综合征 (ACS) 在希腊独特的岛屿人口中,COVID-19大流行期间的住院病例并没有下降. 这项研究发现,在封锁期间,ACS发病率或患者结局没有变化.
科学领域:
- 心脏病学 心脏病学
- 流行病学 流行病学
- 公共卫生 公共卫生
背景情况:
- 全球报告显示,在COVID-19大流行期间,急性冠状动脉综合征 (ACS) 的住院患者数量有所减少.
- 希腊岛屿基奥斯在封锁期间经历了最小的COVID-19病例,为研究ACS趋势提供了一个独特的环境.
研究的目的:
- 为了比较COVID-19封锁期间与前一年同期期间在基奥斯总医院的ACS医院入院情况.
- 评估大流行是否影响了孤立人口中的ACS发病率,类型或患者结局.
主要方法:
- 基奥斯总医院的医院记录的回顾性分析.
- 在2020年2月26日至2020年5月4日和2019年2月26日之间ACS发病率,类型和并发症的比较.
- 将症状发作数据纳入医疗接触,血液动力学状态和左心室功能.
主要成果:
- 每10,000名居民的ACS住院病例在2020年为1.72人,而在2019年为1.03人 (p = 0.317),没有显示出统计学上显著的差异.
- 在这两个时期之间,在ACS类型,医疗接触的时间,血液动力学状态,左心室功能或并发症方面没有发现显著差异.
结论:
- 在这个孤立的希腊岛屿人口中,急性冠状动脉综合征的发病率在COVID-19大流行期间没有下降.
- 对ACS的患者预后保持稳定,在这种COVID-19影响较低的社区中,在大流行锁定期间没有观察到结果恶化.
更多相关视频
05:41Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
Published on: December 16, 2022
3.3K
15:00Setup of Consumer Wearable Devices for Exposure and Health Monitoring in Population Studies
Published on: February 3, 2023
2.4K
相关概念视频
01:30Acute Coronary SyndromeI: Introduction
15
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
15
01:30Acute Coronary Syndrome III: Diagnostic studies
3
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
3
01:28Acute Coronary Syndrome IV: Interprofessional Care
3
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
3
01:19Acute Coronary Syndrome II: Pathophysiology and clinical manifestations
3
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
3
01:27Coronary Artery Disease V: Surgical Management
3
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
3
01:30Coronary Artery Disease III: Clinical Manifestations
3
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
3